The deposition of protein aggregates in various parts of our body gives rise to several devastating diseases, and the development of probes for the selective detection of aggregated proteins is crucial to advance our understanding of the pathogenesis underlying these diseases. LCPs (luminescent conjugated polythiophenes) are fluorescent probes that bind selectively to protein aggregates. The conjugated thiophene backbone is flexible and offers a connection between the conformation and the emission properties, hence binding of LCPs gives the molecule a spectral fingerprint. The present review covers the utilization of LCPs to study the heterogeneity of protein aggregates. It emphasizes specifically the introduction of welldefined probes called LCOs (luminescent conjugated oligothiophenes) and reports how these molecules can be used for real-time in vivo imaging of cerebral plaques as well as for spectral discrimination of protein aggregates and detection of early species in the fibrillation pathway of amyloid β-peptide.
Introduction
In the strive for developing sensors sensitive enough to monitor complex biological processes in the human body, the attention has for several years been turned to the unique properties of CPs (conjugated polymers). Traditionally, CPs have been utilized in various electronic devices such as solar cells and light-emitting diodes and were put into the limelight in 2000 when Alan J. Heeger, Alan G. MacDiarmid and Hideki Shirakawa were awarded the Nobel Prize for the discovery and development of conductive polymers. However, the polymeric structure in synergy with the organization of electrons along the backbone also makes CPs excellent biosensors since the arrangement gives a connection between the conformation of the backbone and the optical properties of the conjugated system [1] . Additionally, CPs display a molecular similarity with biological polymers, which leads to the formation of strong complexes between the CP and the biomolecule of interest [2] . Hence CPs can be used to give a molecule a spectral fingerprint that corresponds to the conformation of that molecule, an ability that was utilized by Nilsson et al. in 2003 [3] to successfully discriminate between synthetic peptides having a random-coil conformation or a four-helix-bundle motif. This was the starting point of using polymers based Key words: amyloid β-peptide (Aβ), conjugated polymer, luminescent conjugated oligothiophene, luminescent conjugated polythiophene, thioflavin T. Abbreviations used: Aβ, amyloid β-peptide; AD, Alzheimer's disease; BBB, bloodbrain barrier; CP, conjugated polymer; FTAA, formyl thiophene acetic acid; h-, heptameric; HTAA, hydrogen thiophene acetic acid; LCO, luminescent conjugated oligothiophene; LCP, luminescent conjugated polythiophene; MDB, Mallory-Denk body; NFT, neurofibrillary tangle; p-, pentameric; PTAA, polythiophene acetic acid; ThT, thioflavin T; tPTT, poly (5, 5 ) on a thiophene backbone, so-called LCPs (luminescent conjugated polythiophenes), to visualize and study distinct conformational variants of proteins, in particular when the polypeptide chain has lost its native fold and starts to form aggregates.
Protein misfolding diseases include a wide range of human diseases caused by the failure of a protein to adopt or maintain its native functional state [4] . Amyloidosis constitutes the largest group of protein misfolding diseases and is characterized by the deposition of protein aggregates (amyloid) in various parts of the body [4, 5] . The first protein to be identified in amyloid deposits was the immunoglobulin light chain [6] and, with time, 27 proteins have been classified as amyloidogenic [7, 8] , causing diseases such as AD (Alzheimer's disease) and the infectious prion diseases [4] . Amyloid fibrils share the same structural characteristics and have a long, unbranched morphology with the polypeptide chain arranged to form parallel β-strands that run perpendicular to the axis of the fibre, known as the cross-β pattern [9] [10] [11] . The structural rearrangements of the native protein when being converted into amyloid make it difficult to use conventional antibody staining for diagnosis. Most of the antibodies cannot separate the normal native fold of the protein from the pathological amyloid fold, which might cause false-positive staining, and the dense packing of deposits might hide the antibody epitope and thereby cause false-negative staining [12, 13] . Derivatives of Congo Red and ThT (thioflavin T) have for a long time been used for the detection of amyloid proteins. The affinity of Congo Red with a resulting yellow-green birefringence is one of the amyloid criteria [14] [15] [16] and ThT has been extensively used to follow the aggregation of proteins in vitro [17, 18] . However, the introduction of LCPs, and later the well-defined LCOs (luminescent conjugated oligothiophenes), as amyloid imaging agents has revealed the advantages of using a flexible backbone compared with the sterically rigid scaffold found in Congo Red and ThT. The connection between conformation and optical properties has made it possible to study the conformational diversity on the molecular level among amyloids and to identify a broader subset of protein aggregates. The present review covers the introduction of CPs to the world of protein aggregation diseases and emphasizes specifically the promising results obtained for the recently presented LCOs.
LCPs as optical amyloid ligands: the proof of concept
The major advantage of using CPs for detection and imaging of biomolecules is that any change in the conformation of the flexible backbone can be monitored optically since it alters the absorption and/or the emission properties of the CP. Hence, if the interaction between a CP and a biological target, such as a protein aggregate, alters the backbone structure, a specific spectroscopic signature can be achieved from the distinct biomolecule [1, 19, 20] . In 2005, Nilsson et al. [21] utilized the colour change of the anionic LCP PTAA (polythiophene acetic acid) ( Figure 1A ) when binding to insulin fibrils compared with native insulin to follow the fibrillation kinetics of the protein. However, a second generation of LCPs with affinity only for proteins that display a fibrillar conformation was soon presented [22] . These LCPs were built from a trimeric building block containing unsubstituted thiophene rings ( Figure 1A ) and this modification not only enhanced the discrimination between the native and fibrillar state substantially, but also increased the quantum yield. The next step was to prove that the specificity of the LCPs against the amyloid fold was kept also in more complex environments such as tissue. Nilsson et al. [23] developed the proof of concept in 2006 and, since then, tissues from many different organs containing various types of amyloid have been analysed. The staining results have consistently shown specific binding of LCPs to protein deposits and have, in some cases, also revealed spectral differences between aggregates ( Figure 1 ).
Spectral discrimination of aggregates by using LCPs
The real strength of the LCP technique is its ability to detect subtle differences between protein aggregates due to alterations of the thiophene backbone. As mentioned above, amyloids from different sources share many structural similarities despite the divergent primary fold; however, high-resolution information has revealed that amyloids show a diversity of structures at the molecular level [24] . Conformational heterogeneity has previously been reported for prion aggregates and has given rise to the definition of various prion strains [25, 26] . Prion deposits in mice originating from scrapie-infected sheep or chronic wasting disease-infected cervids constitute different strains and can be spectrally discriminated when labelled with PTAA, confirming the variation in conformation ( Figures 1C and  1D ) [27] . Spectral analysis of plaque-bound PTAA has also revealed that prion strains interact highly selectively to form hybrid plaques or to block fibrillation of each other [28] . In addition, the LCP-based strain technology has also shed light on conformational variants of Aβ (amyloid β-peptide) aggregates in transgenic mouse models with AD pathology [29] . Staining of brain tissue from tgAPP-Swe mice with the LCP tPTT [poly (5, 5 ) Figure 1A ) revealed Aβ plaques with significant variations in the spectral profile. The most abundant type of plaque had a compact core with a diffuse exterior. Surprisingly, when binding to an LCP, the centre was shown to be more disordered compared with the rigid amyloid found in the exterior, which was seen as emission of green and red light respectively ( Figures 1E and 1F ). This finding was confirmed when the spectral result of LCPs binding to Aβ fibrils formed in vitro was in high accordance with the ultrastructural analysis, with disordered fibrils displaying a green-shifted emission spectrum and straight fibrils a red-shifted emission spectrum. The results taken together led the authors to speculate whether the solidified amyloid tentacles were growing and protruding from the disordered centre or if the opposite scenario with rigid amyloid fibrils generating a plaque that grows from the outside in was more likely [29] . In either case, the LCP conformational analysis had shown proof of adding knowledge to the yet unexplored territory of amyloid-spreading pathways and has later also been used to determine the structural difference between deposited Aβ in tgAPP-Swe and tgAPP-ArcSwe mice [30] as well as spectrally distinguish aggregates of amyloid light chain, serum amyloid A and transthyretin in human patients [31] .
The next generation of thiophene-based amyloid probes
The LCPs discussed so far are based on a polymeric backbone with the majority of the thiophene rings functionalized with ionic side chains. This naturally implies a high molecular mass and an electronic charge that prevent the LCPs from passing the BBB (blood-brain barrier). In 2009, Å slund et al. [32] presented a novel class of smaller LCPs called LCOs that were based on a pentameric thiophene backbone. In comparison with LCPs, these molecules were able to function as specific amyloid agents under physiological conditions (in PBS), which is a prerequisite if they are to be used as imaging probes in vivo. All three tested LCOs showed high fluorescence intensity and well-defined emission spectra when bound to cerebral plaques in AD transgenic mice. The lower number of ionic side chains increased the exposure of the backbone, which seemed to enhance the interaction with the amyloid fibrils and thereby result in higher fluorescence intensity. Since this new generation of probes showed high specificity in PBS, the authors explored whether the LCOs could be utilized as in vivo imaging agents of cerebral plaques in aged transgenic AD mice. After being injected into the tail vein, two of the LCOs, termed p-(pentameric) HTAA (hydrogen thiophene acetic acid) and p-FTAA (formyl thiophene acetic acid), passed the BBB effectively and selectively labelled the deposits. By using a cranial window and multiphoton microscopy, specific staining of Aβ plaques could be observed as early as 6 min after the injection of p-HTAA and the intensity was still high 1 week after injection [32] . Hence the LCOs can be added to the exclusive group of probes that has the potential to be used as amyloid-imaging agents in humans. Other members of this group are Methoxy-X04 [33] , a Congo Red derivative, and Pittsburgh Compound B, a derivative of ThT that has been used successfully for imaging plaques in human AD patients [34, 35] .
As mentioned in the previous sections, staining with LCPs has been used to spectrally separate protein aggregates associated with distinct prion strains. The same result was achieved when using p-FTAA, which indicated that p-FTAA exhibited conformation-sensitive properties [32] . When the probe was applied to brain cryosections from AD patients it clearly labelled the histopathological hallmarks associated with AD, such as Aβ plaques, dystrophic neurites and NFTs (neurofibrillary tangles) and showed complete co-localization with conventional Aβ and tau antibodies. Excitingly, aggregated Aβ and tau seemed to have diverse impacts on the p-FTAA conjugation length, which was observed as a variation in λ em . p-FTAA bound to Aβ plaques emitted green light with two distinct emission peaks, whereas the light observed from aggregated tau was red-shifted. These distinct spectral fingerprints were only obtained with p-FTAA, extension of the backbone (PTAA) or removal of the carboxy end-groups (p-HTAA) abolished the phenomenon [32] . Apparently, in order to achieve a spectral discrimination of Aβ and tau, the design of the LCO seemed to be crucial, and the synthesis of a library of structurally diverse LCOs has been performed to shed some light on the relationship between structure and spectral performance [36] . The study included nine LCOs with a backbone length varying from four to seven thiophene rings and with end thiophenes replaced with either hydrogen or a carboxy group. As expected, all LCOs selectively labelled Aβ deposits, NFTs and dystrophic neurites in cryosectioned brain tissue from AD patients. However, to obtain a difference of colour between Aβ plaques and NFTs, the structural requirements were found to be a backbone consisting of five to seven thiophene rings and a carboxy group attached to the end thiophene unit (Figure 2) . When comparing the resulting spectra after exciting the probes at a blue and red wavelength and then merging the emission spectra, it became clear that binding of p-FTAA resulted in the most distinct spectral fingerprints ( Figure 2D ). Since the LCP PTAA and several of the LCOs failed to spectrally discriminate the two protein entities, the effect could not be explained by Aβ and tau having different conformations, but rather to be dependent on some kind of interplay between the carboxy end-groups and chemical groups in the binding pocket of tau extending the conjugation length [36] .
Another desirable property that none of the LCPs have been shown to possess is the ability to detect prefibrillar species formed early in the protein aggregation pathways. The difficulties in correlating the severity of dementia with plaque load in AD have led to the soluble oligomeric species emerging as the primary toxic agents [37] [38] [39] [40] and many researchers are now focused on finding molecules able to detect these early species. Recently, Jovin and co-workers presented an ESIPT (excited-state intramolecular proton transfer) probe sensitive to early and intermediate stages of α-synuclein aggregation [41] , and p-FTAA has been reported to detect prefibrillar species of Aβ, insulin, lysozyme and the prion protein not detected with ThT [42] . The ability of LCOs to bind early stages in the fibrillation pathway of Aβ has been reported to be highly dependent on the design [36] . When the library of structurally diverse LCOs was used to monitor the fibrillation kinetics of recombinant Aβ 1-42 , a backbone consisting of four thiophene rings displayed the same Aβ kinetic pattern as ThT (Figure 3A) , whereas the extension with one thiophene unit made it possible to detect prefibrillar species that were non-thioflavinophilic ( Figure 3B ). To increase further the number of thiophene rings to obtain a hexameric or heptameric backbone did not enhance or abolish the detection ability and the type of chemical end-group did not exert any influence ( Figure 3C ) [36] . Hence LCOs with a backbone consisting of five to seven thiophene rings are able to detect early species not found with the conventional probe ThT and will certainly aid in our understanding of the mechanisms behind the cell death seen in protein misfolding diseases.
The study of intracellular protein aggregates
Intracellular protein aggregates, or inclusion bodies, are found in a variety of diseases, but tau is so far the only protein to form intracellular aggregates that fulfils the requirements to be defined as amyloidogenic [7] . MDBs (Mallory-Denk bodies) are hepatic inclusion bodies seen in various chronic liver disorders such as steatohepatitis and hepatocellular neoplasms [43] . Recently, p-FTAA and the heptameric (h-) LCO h-HTAA were shown to specifically label misfolded keratin forming MDBs in transfected cells, a mouse model and human liver tissue. Other types of hepatic protein inclusions containing p62 and ubiquitin, but not keratin, remained unstained with h-HTAA, indicating that keratin was the protein displaying the cross-β-sheet structure recognized by the LCOs [44] . MDBs consist of keratin 8 and keratin 18, and earlier experiments have revealed keratin 8 to be more prone to form aggregates [43] . This result was confirmed with h-HTAA staining of transfected cells, which showed that keratin 8 spontaneously acquired a cross-β-sheet structure, whereas keratin 18 inclusions positive for h-HTAA only were found after the cells were exposed to oxidative stress [44] . These results clearly show that LCOs can be applied to study intracellular protein aggregates, a property that is highly valued since several studies indicate that the formation of amyloid in many cases is initiated inside the cell [45, 46] .
Conclusions
The present review describes the introduction of conjugated polymers into the world of protein misfolding diseases. The unique connection between backbone conformation and optical properties has given the key to explore the unknown mechanisms behind amyloid spreading and to investigate the conformational heterogeneity reported for several amyloidogenic proteins. Thiophene-based polymers and their oligomeric counterparts have been proven useful in a number of applications and can, for example, be utilized to spectrally discriminate Aβ plaques and NFTs in histological samples and to detect early prefibrillar species of Aβ in vitro. The novel oligomeric scaffold allows efficient crossing over the BBB and can be modified further to suit imaging techniques such as MRI (magnetic resonance imaging) and PET (positron emission tomography). The implementation of CPs in the area of protein misfolding shows great promise, and the continuous development of the scaffold will generate molecules that can serve as important tools both within research and in the field of diagnostics.
